Page values for "Hydroquinone"
Appearance
"Medicines" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| generic | String | Hydroquinone |
| brand | String | Lustra, EpiQuin Micro, Melquin, Tri-Luma (with tretinoin and fluocinolone) |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Skin_lightening_agents|Skin-lightening agent]] • [[:Category:Depigmenting_agents|Depigmenting agent]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-00001215-QINU`"', '"`UNIQ--vote-00001216-QINU`"', '"`UNIQ--vote-00001217-QINU`"' |
| starting_dose | String | Apply thin layer to hyperpigmented areas BID; limit to 4-6 month courses to avoid ochronosis |
| preparations | String | 4% prescription cream/lotion; OTC 2% withdrawn in US (2020 CARES Act); compounded higher strengths available |
| fda_max | String | 4% topical; limit duration of use |
| pill_id | Text | |
| routes | List of String, delimiter: , | Topical |
| onset | String | Visible lightening at 4-12 weeks |
| duration | String | Hours per application |
| halflife | String | Not meaningfully described — topical local action with minimal systemic absorption'"`UNIQ--ref-00001218-QINU`"' |
| bioavailability | String | Topical with limited but measurable systemic absorption'"`UNIQ--ref-00001219-QINU`"' |
| pregnancy | String | Generally avoided in pregnancy.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US since 2020 (OTC 2% formulations withdrawn under CARES Act due to safety concerns) |